https://srt1720activator.com/r....esonant-type-piezoel
Patients are treated with one 20-mg trimetazidine tablet or placebo thrice daily (twice daily when it comes to moderate renal dysfunction) for just two durations of 3 months separated by a 2-week washout period. The primary endpoint may be the improvement in pulmonary capillary wedge force during different intensities of workout calculated by right heart catheterisation. Our crucial secondary endpoint is the myocardial phosphocreatine (PCr)/ATP ratio calculated by phospho
Like
Comment
Share
